FOXO1 and neoplasm: aRMS is a highly aggressive tumor is characterized by the pathogenomic t(1:13) or t(2:13) translocation resulting in the chimeric gene-fusion product PAX3:FOXO1 or PAX7:FOXO1, respectively [1].